Smart Wearable Ozone Therapy System for Managing Multidrug-Resistant Wound Infections

IF 3.2 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Akshay Krishnakumar, Alexander Roth, Praveen Srinivasan, Muhammad Masud Rana, Nicholas L. F. Gallina, Devendra Sarnaik, Robyn R. McCain, Abigail D. Cox, Mohamed N. Seleem, Arun K. Bhunia, Rahim Rahimi
{"title":"Smart Wearable Ozone Therapy System for Managing Multidrug-Resistant Wound Infections","authors":"Akshay Krishnakumar,&nbsp;Alexander Roth,&nbsp;Praveen Srinivasan,&nbsp;Muhammad Masud Rana,&nbsp;Nicholas L. F. Gallina,&nbsp;Devendra Sarnaik,&nbsp;Robyn R. McCain,&nbsp;Abigail D. Cox,&nbsp;Mohamed N. Seleem,&nbsp;Arun K. Bhunia,&nbsp;Rahim Rahimi","doi":"10.1002/adtp.202500541","DOIUrl":null,"url":null,"abstract":"<p>Multidrug-resistant (MDR) bacterial infections represent a critical challenge in wound care, leading to treatment failure, prolonged healing, and increased morbidity and mortality worldwide. Among MDR pathogens, <i>Pseudomonas aeruginosa</i> is particularly problematic due to its adaptive resistance mechanisms, underscoring the urgent need for alternative, non-antibiotic therapeutic strategies. Ozone has demonstrated potent antimicrobial efficacy while promoting wound healing and exhibiting a low propensity for resistance development; however, conventional ozone delivery systems are bulky, poorly suited for ambulatory use, and pose risks of environmental leakage and unintended exposure. To address these limitations, we have developed a smart wearable ozone therapy system capable of precise, localized ozone delivery directly to the wound bed. The platform integrates on-demand ozone generation, real-time sensing, and controlled air circulation within a compact, reusable unit, coupled to a disposable wound interface patch via double-lumen tubing. Embedded sensors continuously regulate ozone concentrations within therapeutic windows while detecting leakage and triggering automatic shutdown to ensure patient and environmental safety. System characterization demonstrated that localized low-level ozone exposure (75 ppm), when combined with Vancomycin (400 µg·mL<sup>−</sup><sup>1</sup>), eradicated planktonic bacterial cultures to undetectable levels within 4 h while maintaining minimal cytotoxicity toward mammalian cells. For the first time, this fully integrated wearable platform was validated in a <i>Pseudomonas aeruginosa–</i>infected porcine wound model, achieving approximately 90% bacterial reduction after four consecutive daily 6 h treatments and accelerating wound closure by nearly threefold compared with silver dressings or topical antibiotic treatment alone. These results establish a safe, effective, and translationally viable wearable ozone therapy system for the management of MDR-infected wounds.</p>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"9 3","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adtp.202500541","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adtp.202500541","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Multidrug-resistant (MDR) bacterial infections represent a critical challenge in wound care, leading to treatment failure, prolonged healing, and increased morbidity and mortality worldwide. Among MDR pathogens, Pseudomonas aeruginosa is particularly problematic due to its adaptive resistance mechanisms, underscoring the urgent need for alternative, non-antibiotic therapeutic strategies. Ozone has demonstrated potent antimicrobial efficacy while promoting wound healing and exhibiting a low propensity for resistance development; however, conventional ozone delivery systems are bulky, poorly suited for ambulatory use, and pose risks of environmental leakage and unintended exposure. To address these limitations, we have developed a smart wearable ozone therapy system capable of precise, localized ozone delivery directly to the wound bed. The platform integrates on-demand ozone generation, real-time sensing, and controlled air circulation within a compact, reusable unit, coupled to a disposable wound interface patch via double-lumen tubing. Embedded sensors continuously regulate ozone concentrations within therapeutic windows while detecting leakage and triggering automatic shutdown to ensure patient and environmental safety. System characterization demonstrated that localized low-level ozone exposure (75 ppm), when combined with Vancomycin (400 µg·mL−1), eradicated planktonic bacterial cultures to undetectable levels within 4 h while maintaining minimal cytotoxicity toward mammalian cells. For the first time, this fully integrated wearable platform was validated in a Pseudomonas aeruginosa–infected porcine wound model, achieving approximately 90% bacterial reduction after four consecutive daily 6 h treatments and accelerating wound closure by nearly threefold compared with silver dressings or topical antibiotic treatment alone. These results establish a safe, effective, and translationally viable wearable ozone therapy system for the management of MDR-infected wounds.

Abstract Image

用于管理耐多药伤口感染的智能可穿戴臭氧治疗系统
耐多药(MDR)细菌感染是伤口护理的一个重大挑战,导致治疗失败、愈合时间延长以及全球发病率和死亡率增加。在耐多药病原体中,铜绿假单胞菌由于其适应性耐药机制而特别成问题,强调迫切需要替代的非抗生素治疗策略。臭氧在促进伤口愈合的同时显示出强大的抗菌功效,并表现出较低的耐药性发展倾向;然而,传统的臭氧输送系统体积庞大,不适合流动使用,并且存在环境泄漏和意外暴露的风险。为了解决这些限制,我们开发了一种智能可穿戴臭氧治疗系统,能够精确地将局部臭氧直接输送到伤口床。该平台集成了按需臭氧生成、实时传感和可控制的空气循环,在一个紧凑的、可重复使用的单元中,通过双腔管连接到一次性伤口接口贴片。嵌入式传感器不断调节治疗窗口内的臭氧浓度,同时检测泄漏并触发自动关闭,以确保患者和环境安全。系统表征表明,局部低水平臭氧暴露(75 ppm)与万古霉素(400µg·mL−1)联合使用,可在4小时内将浮游细菌培养物清除到检测不到的水平,同时保持对哺乳动物细胞的最小细胞毒性。这种完全集成的可穿戴平台首次在铜绿假单胞菌感染的猪伤口模型中进行了验证,在连续四次每天6小时的治疗后,细菌减少了约90%,与单独使用银敷料或局部抗生素治疗相比,伤口愈合速度加快了近三倍。这些结果为耐多药感染伤口的治疗建立了一种安全、有效、可行的可穿戴臭氧治疗系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advanced Therapeutics
Advanced Therapeutics Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.10
自引率
2.20%
发文量
130
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书